Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allopurinol Interferes With the Pathological Mechanisms of Hepatic Decompensation

NCT07033533 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07033533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07033533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allopurinol Interferes With the Pathological Mechanisms of Hepatic Decompensation
Lead sponsor
Tanta University
Phase
Phase 1/2
Overall status
Completed
Start date
June 1, 2023
Completion date
March 1, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhoses, liver